Overview

Effect of Bupropion on Seizure Threshold in Depressed Patients

Status:
Completed
Trial end date:
2018-05-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to examine the effect of bupropion on seizure threshold and duration in depressed patients receiving right unilateral ultra-brief electroconvulsive therapy (ECT). The investigators plan to recruit 10 patients into the study, administer sustained release (SR) bupropion 4 hours prior to receiving ECT. The investigators plan to compare the seizure threshold and seizure durations between ECT sessions with and without bupropion administration. The study's implication is to examine how ECT can be optimized by rational combination with medications that lower seizure threshold.
Phase:
Phase 4
Details
Lead Sponsor:
Duke University
Treatments:
Bupropion